WO2011097946A8 - 含有并环稠合双环的噁唑烷酮化合物及其制备和应用 - Google Patents

含有并环稠合双环的噁唑烷酮化合物及其制备和应用 Download PDF

Info

Publication number
WO2011097946A8
WO2011097946A8 PCT/CN2011/000159 CN2011000159W WO2011097946A8 WO 2011097946 A8 WO2011097946 A8 WO 2011097946A8 CN 2011000159 W CN2011000159 W CN 2011000159W WO 2011097946 A8 WO2011097946 A8 WO 2011097946A8
Authority
WO
WIPO (PCT)
Prior art keywords
ring
fused bicyclic
compounds containing
preparation
oxazolidinone compounds
Prior art date
Application number
PCT/CN2011/000159
Other languages
English (en)
French (fr)
Other versions
WO2011097946A1 (zh
Inventor
黄振华
周广连
宋运涛
Original Assignee
山东轩竹医药科技有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 山东轩竹医药科技有限公司 filed Critical 山东轩竹医药科技有限公司
Priority to CN201180004791.XA priority Critical patent/CN102762553B/zh
Publication of WO2011097946A1 publication Critical patent/WO2011097946A1/zh
Publication of WO2011097946A8 publication Critical patent/WO2011097946A8/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
PCT/CN2011/000159 2010-02-11 2011-01-30 含有并环稠合双环的噁唑烷酮化合物及其制备和应用 WO2011097946A1 (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201180004791.XA CN102762553B (zh) 2010-02-11 2011-01-30 含有并环稠合双环的噁唑烷酮化合物及其制备和应用

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CN201010123852.1 2010-02-11
CN201010123852 2010-02-11
CN2010102017403A CN102153547A (zh) 2010-02-11 2010-06-08 含有并环的噁唑烷酮抗菌素
CN201010201740.3 2010-06-08

Publications (2)

Publication Number Publication Date
WO2011097946A1 WO2011097946A1 (zh) 2011-08-18
WO2011097946A8 true WO2011097946A8 (zh) 2012-07-26

Family

ID=44367235

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2011/000159 WO2011097946A1 (zh) 2010-02-11 2011-01-30 含有并环稠合双环的噁唑烷酮化合物及其制备和应用

Country Status (2)

Country Link
CN (2) CN102153547A (zh)
WO (1) WO2011097946A1 (zh)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102153547A (zh) * 2010-02-11 2011-08-17 山东轩竹医药科技有限公司 含有并环的噁唑烷酮抗菌素
EP2762479A4 (en) * 2011-09-29 2015-04-22 Xuanzhu Pharma Co Ltd OXAZOLIDINONE ANTIBACTERIAL MEDICINE BASED ON BIARYLIC HETEROCYCLE SUBSTITUTED
EP2762480A4 (en) 2011-09-30 2015-03-18 Xuanzhu Pharma Co Ltd OXAZOLIDINONIBIOTICS WITH CONDENSED RINGS
CN103709085B (zh) * 2012-09-28 2016-03-09 山东亨利医药科技有限责任公司 截短侧耳素类抗生素
CN104884452A (zh) 2012-11-20 2015-09-02 沃泰克斯药物股份有限公司 用作吲哚胺2,3-二氧化酶的抑制剂的化合物
EP3180335B1 (en) 2014-08-11 2021-05-05 Angion Biomedica Corporation Cytochrome p450 inhibitors and uses thereof
CN105524008B (zh) * 2014-10-21 2018-09-07 山东轩竹医药科技有限公司 噁唑烷酮抗菌药中间体的制备方法
JP2018501279A (ja) 2014-12-31 2018-01-18 アンギオン バイオメディカ コーポレイション 疾患を治療するための方法及び薬剤
CN110776429B (zh) * 2018-07-30 2022-12-02 齐鲁制药有限公司 一种雷沙吉兰消旋中间体的改进制备方法
CN109053566A (zh) * 2018-09-13 2018-12-21 江苏师范大学 一种2-甲基喹啉的合成方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU667198B2 (en) * 1991-11-01 1996-03-14 Pharmacia & Upjohn Company Substituted aryl- and heteroarylphenyloxazolidinones useful as antibacterial agents
CA2405532A1 (en) * 2001-02-07 2002-08-22 Ortho-Mcneil Pharmaceutical, Inc. Pyridoarylphenyl oxazolidinone antibacterials, and related compositions and methods
WO2006035283A1 (en) * 2004-09-27 2006-04-06 Ranbaxy Laboratories Limited Oxazolidinone derivatives as antimicrobials
CN102131811A (zh) * 2008-06-24 2011-07-20 财团法人乙卯研究所 具有稠合环的*唑烷酮衍生物
CN102153547A (zh) * 2010-02-11 2011-08-17 山东轩竹医药科技有限公司 含有并环的噁唑烷酮抗菌素

Also Published As

Publication number Publication date
WO2011097946A1 (zh) 2011-08-18
CN102153547A (zh) 2011-08-17
CN102762553B (zh) 2016-10-19
CN102762553A (zh) 2012-10-31

Similar Documents

Publication Publication Date Title
WO2011097946A8 (zh) 含有并环稠合双环的噁唑烷酮化合物及其制备和应用
MX2020003055A (es) Compuestos de carbamoilpiridona policiclicos y su uso farmaceutico.
WO2008154642A3 (en) Antibacterial agents
WO2020257549A3 (en) Compounds for treatment of pd-l1 diseases
WO2012021796A8 (en) Novel cyclosporin derivatives for the treatment and prevention of a viral infection
MX2017007814A (es) Compuesto de carbamoilpiridona policiclicos y su uso farmaceutico.
WO2010088000A3 (en) Antifibrotic compounds and uses thereof
WO2004062601A3 (en) Antibacterial agents
MX2017012393A (es) Compuestos de carbamoilpiridona policiclicos y su uso farmaceutico.
WO2010084115A3 (en) Antiviral agents
MX2014004479A (es) Derivados de oxazina novedosos y su uso en el tratamiento de enfermedades.
TW200640908A (en) Chemical compounds
WO2012009715A3 (en) Novel cyclosporin derivatives for the treatment and prevention of a viral infection
NZ703064A (en) Inhibitors of hepatitis c virus
MX2010009163A (es) Derivados heterociclicos de urea y metodos de uso de los mismos-211.
MX2011012122A (es) Derivados de tiofeno.
WO2012018534A3 (en) Substituted biphenylene compounds and methods of use thereof for the treatment of viral diseases
MX2013014007A (es) [1,3] oxazinas.
WO2008020227A3 (en) Antibacterial pyrrolecarboxamides
WO2008020229A3 (en) Antibacterial pyrrolecarboxamides
WO2013112959A8 (en) Antifibrotic compounds and uses thereof
MX2009013501A (es) Compuestos piperidinicos y sus usos.
MX350746B (es) Derivados de ciclosporina novedosos para el tratamiento y la prevención de una infección viral.
WO2006039263A3 (en) NOVEL BICYCLIC 9a-AZALIDE DERIVATIVES
WO2012030914A8 (en) 4-azolylaminoquinazoline derivatives and methods of use thereof

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 201180004791.X

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11741817

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase in:

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11741817

Country of ref document: EP

Kind code of ref document: A1